Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology:: A population-based, 5-year follow-up study

被引:219
作者
Molano, M
van den Brule, A
Plummer, M
Weiderpass, E
Posso, H
Arslan, A
Meijer, CJLM
Muñoz, N
Franceschi, S
机构
[1] Int Agcy Res Canc, F-69372 Lyon 08, France
[2] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands
[3] Inst Nacl Cancerol, Div Invest, Bogota, Colombia
关键词
cervix neoplasms; cohort studies; cytology; oral contraceptives; papillomavirus;
D O I
10.1093/aje/kwg171
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Little is known about the factors that influence clearance of human papillomavirus (HPV), the primary cause of cervical carcinoma. A total of 227 women cytologically normal and HPV positive at baseline were identified from a population-based cohort of 1,995 Bogota, Colombia, women aged 13-85 years followed between 1993 and 2000 (mean follow-up, 5.3 years). HPV DNA detection and viral load determination were based on a GP5+/GP6+ polymerase chain reaction enzyme immunoassay. Rate ratio estimates for HPV clearance were calculated by using methods for interval-censored survival time data. Analyses were based on 316 type-specific HPV infections. HPV 16 had a significantly lower clearance rate than infections with low-risk types (rate ratio (RR)=0.47, 95% confidence interval (CI): 0.32, 0.72), HPV types related to HPV 16 (types 31, 33, 35, 52, 58) had intermediate clearance rates (RR=0.62, 95% CI: 0.47, 0.94), and other high-risk types did not show evidence of slower clearance compared with low-risk types. Infections with single and multiple HPV types had similar clearance rates. There was no evidence of a dose-response relation between clearance and viral load. Observed was slower clearance in parous women (RR=0.64, 95% CI: 0.47, 0.89) and faster clearance in ever users of oral contraceptives (RR=1.38, 95% CI: 1.07, 1.77).
引用
收藏
页码:486 / 494
页数:9
相关论文
共 61 条
  • [1] Human papillomavirus type 18: Association with poor prognosis in early stage cervical cancer
    Burger, RA
    Monk, BJ
    Kurosaki, T
    AntonCulver, H
    Vasilev, SA
    Berman, ML
    Wilczynski, SP
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (19): : 1361 - 1368
  • [2] Castle PE, 2002, JNCI-J NATL CANCER I, V94, P1406, DOI 10.1093/jnci/94.18.1406
  • [3] Human papillomavirus types in invasive cervical cancer worldwide:: a meta-analysis
    Clifford, GM
    Smith, JS
    Plummer, M
    Muñoz, N
    Franceschi, S
    [J]. BRITISH JOURNAL OF CANCER, 2003, 88 (01) : 63 - 73
  • [4] Screening for cervical cancer
    Cuzick, J
    Meijer, CJLM
    Walboomers, JMM
    [J]. LANCET, 1998, 351 (9113) : 1439 - 1440
  • [5] Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort
    Deacon, JM
    Evans, CD
    Yule, R
    Desai, M
    Binns, W
    Taylor, C
    Peto, J
    [J]. BRITISH JOURNAL OF CANCER, 2000, 83 (11) : 1565 - 1572
  • [6] A population-based five-year follow-up study of cervical human papillomavirus infection
    Elfgren, K
    Kalantari, M
    Moberger, B
    Hagmar, B
    Dillner, J
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (03) : 561 - 567
  • [7] THE ASSOCIATION OF AN HPV16 ONCOGENE VARIANT WITH HLA-B7 HAS IMPLICATIONS FOR VACCINE DESIGN IN CERVICAL-CANCER
    ELLIS, JRM
    KEATING, PJ
    BAIRD, J
    HOUNSELL, EF
    RENOUF, DV
    ROWE, M
    HOPKINS, D
    DUGGANKEEN, MF
    BARTHOLOMEW, JS
    YOUNG, LS
    STERN, PL
    [J]. NATURE MEDICINE, 1995, 1 (05) : 464 - 470
  • [8] Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer
    Franco, EL
    Villa, LL
    Sobrinho, JP
    Prado, JM
    Rousseau, MC
    Désy, M
    Rohan, TE
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (05) : 1415 - 1423
  • [9] Franco EL, 1997, NEW DEVELOPMENTS IN CERVICAL CANCER SCREENING AND PREVENTION, P14
  • [10] Cervical cancer in older women: A molecular analysis of human papillomavirus types, HLA types, and p53 mutations
    Gostout, BS
    Podratz, KC
    McGovern, RH
    Persing, DH
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 179 (01) : 56 - 61